Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Etanercept effectively treated a severe skin condition when other treatments failed.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Enhancing Tregs can protect against alopecia areata.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Apremilast may help treat hair loss in alopecia areata.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Cyclosporine combined with other treatments can help hair regrow in severe alopecia areata, but it may cause side effects.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.